investing-statsSEC Form 4 insider transactions

GPCR · Structure Therapeutics Inc.

← all insiders

Pharmaceutical Preparations · Listed on Nasdaq

Open-market insider flow over 30d · 90d · 180d · 365d · filter in table · CSV · JSON

Open-market trades13
Distinct insiders2
Bought$0
Sold$2.35M
Net flow$-2.35M

Recent filings

How to read this

Filed
Date the Form 4 was filed with the SEC. Insiders must file within 2 business days of the trade.
Ticker
The issuer's stock symbol. Select it to open that company's insider-activity page.
Issuer
The company whose shares were traded.
Sector
The issuer's industry (SEC SIC classification). Select a value to filter to that sector.
Insider
The reporting person: an officer, director, or 10% owner. Select a name to see all of their trades.
Role
The insider's relationship to the company: director, officer, or 10% owner.
Code
SEC transaction code describing the kind of transaction. Full official definitions are under “Transaction codes” below. A dot marks an open-market trade (P/S), the highest-conviction signal.
Side
Direction of the trade, from the filing's Acquired (A) ▲ / Disposed of (D) ▼ field: a buy or a sell.
10b5-1
Trade made under a pre-arranged Rule 10b5-1 plan: scheduled in advance, not a discretionary decision (generally lower signal).
Shares
Number of shares in this transaction.
Price
Reported price per share. Blank for grants, gifts, and other trades with no stated price.
Value
Transaction value = shares × price. Left blank for grants, option exercises, gifts, and conversions, which have no cash price (see Own Δ for their impact).
Owned after
Form 4 column “Amount of Securities Beneficially Owned Following Reported Transaction(s)”: shares the insider held (directly or indirectly) immediately after this trade.
Own Δ
How much this trade changed the insider's own holding versus what they held just before it (not a share of the company). +45% grew it by 45%, 2.0× more than doubled it, −100% sold the entire stake, “new” built a position from nothing.
Co. Δ
Change in the insider's stake as a share of the whole company from this trade (transaction shares ÷ shares outstanding). The “(now …)” figure is their resulting total stake. Based on the latest reported shares outstanding; blank when unavailable.
D/I
Form 4 column “Ownership Form: Direct (D) or Indirect (I)”. Indirect holdings (for example, through a trust, fund, or family member) are detailed in the filing's “Nature of Indirect Beneficial Ownership.”
Lag
Days from the trade date to the filing date (Form 4 is due within 2 business days).

Transaction codes

Verbatim from the SEC's General Instructions for Forms 3, 4 and 5.

P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award or other acquisition pursuant to Rule 16b-3(d)
D
Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
F
Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
M
Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
G
Bona fide gift
C
Conversion of derivative security
X
Exercise of in-the-money or at-the-money derivative security
J
Other acquisition or disposition (describe transaction)
Recent Form 4 filings for GPCR
FiledDate the Form 4 was filed with the SEC (due within 2 business days of the trade).InsiderRoleCodeSEC transaction code describing the kind of transaction. See “How to read this” above for the official SEC definition of each code. The dot marks an open-market trade (P/S).SideDirection of the trade: a buy (acquired ▲) or a sell (disposed ▼).SharesNumber of shares in this transaction.PriceReported price per share. Blank for trades with no stated price.ValueTransaction value = shares × price. Left blank for grants, option exercises, gifts, and conversions, which have no cash price (see Own Δ).Owned afterShares the insider held (directly or indirectly) immediately after this trade.Own ΔHow much this trade changed the insider's own holding versus what they held just before it (not a share of the company). +45% grew it by 45%, 2.0× more than doubled it, −100% sold the entire stake, “new” built a position from nothing.Co. ΔChange in the insider's stake as a share of the whole company from this trade (transaction shares ÷ shares outstanding). The “(now …)” figure is their resulting total stake in the company. Based on the latest reported shares outstanding; blank when unavailable.Link to SEC filing
2026-09-02Lin XichenOfficer (CHIEF SCIENTIFIC OFFICER)S sell10b5-1100 100 Ordinary Shares$47.83$4.8K0filing
2026-09-02Lin XichenOfficer (CHIEF SCIENTIFIC OFFICER)S sell10b5-14,539 4,539 Ordinary Shares$47.20$214.3K100filing
2026-09-02Lin XichenOfficer (CHIEF SCIENTIFIC OFFICER)S sell10b5-11,300 1,300 Ordinary Shares$45.86$59.6K4,639filing
2026-09-02Lin XichenOfficer (CHIEF SCIENTIFIC OFFICER)C buy10b5-15,939 5,939 Ordinary Shares5,939filing
2026-09-02Lin XichenOfficer (CHIEF SCIENTIFIC OFFICER)M sell10b5-117,817 17,817 Ordinary Shares125,081filing
2026-09-02Lin XichenOfficer (CHIEF SCIENTIFIC OFFICER)C sell10b5-117,8170228,960−7%−<0.01% (now 0.11%)filing
2026-09-02Lin XichenOfficer (CHIEF SCIENTIFIC OFFICER)M buy10b5-117,8170$0.34$6.1K246,777+8%+<0.01% (now 0.12%)filing
2026-08-19Lin XichenOfficer (CHIEF SCIENTIFIC OFFICER)S sell10b5-1400 1,200 Ordinary Shares$55.05$22.0K0filing
2026-08-19Lin XichenOfficer (CHIEF SCIENTIFIC OFFICER)S sell10b5-1519 1,557 Ordinary Shares$54.20$28.1K400filing
2026-08-19Lin XichenOfficer (CHIEF SCIENTIFIC OFFICER)S sell10b5-13,020 9,060 Ordinary Shares$53.13$160.5K919filing
2026-08-19Lin XichenOfficer (CHIEF SCIENTIFIC OFFICER)C buy10b5-13,939 11,817 Ordinary Shares3,939filing
2026-08-19Lin XichenOfficer (CHIEF SCIENTIFIC OFFICER)M sell10b5-111,817 11,817 Ordinary Shares142,898filing
2026-08-19Lin XichenOfficer (CHIEF SCIENTIFIC OFFICER)C sell10b5-111,8170228,960−5%−<0.01% (now 0.11%)filing
2026-08-19Lin XichenOfficer (CHIEF SCIENTIFIC OFFICER)M buy10b5-111,8170$0.34$4.0K240,777+5%+<0.01% (now 0.11%)filing
2026-08-07Berrios John JosephOfficer (Chief Commercial Officer)A buy174,612 174,612 Ordinary Shares174,612filing
2026-08-07Berrios John JosephOfficer (Chief Commercial Officer)A buy140,7660140,766new+0.07% (now 0.07%)filing
2026-08-05Lin XichenOfficer (CHIEF SCIENTIFIC OFFICER)S sell10b5-1839 2,517 Ordinary Shares$50.03$42.0K0filing
2026-08-05Lin XichenOfficer (CHIEF SCIENTIFIC OFFICER)S sell10b5-13,100 9,300 Ordinary Shares$49.29$152.8K839filing
2026-08-05Lin XichenOfficer (CHIEF SCIENTIFIC OFFICER)C buy10b5-13,939 11,817 Ordinary Shares3,939filing
2026-08-05Lin XichenOfficer (CHIEF SCIENTIFIC OFFICER)M sell10b5-111,817 11,817 Ordinary Shares154,715filing
2026-08-05Lin XichenOfficer (CHIEF SCIENTIFIC OFFICER)C sell10b5-111,8170228,960−5%−<0.01% (now 0.11%)filing
2026-08-05Lin XichenOfficer (CHIEF SCIENTIFIC OFFICER)M buy10b5-111,8170$0.34$4.0K240,777+5%+<0.01% (now 0.11%)filing
2026-07-24FMR LLC10% owner, See Remark 1S sell16,085 48,255 Ordinary Shares$50.07$805.4K16,086filing
2026-07-24FMR LLC10% owner, See Remark 1S sell1,367 4,101 Ordinary Shares$50.07$68.4K1,369filing
2026-07-15Lin XichenOfficer (CHIEF SCIENTIFIC OFFICER)S sell10b5-11,600 4,800 Ordinary Shares$51.71$82.7K0filing
2026-07-15Lin XichenOfficer (CHIEF SCIENTIFIC OFFICER)S sell10b5-16,278 18,834 Ordinary Shares$50.80$318.9K1,600filing
2026-07-15Lin XichenOfficer (CHIEF SCIENTIFIC OFFICER)C buy10b5-17,878 23,634 Ordinary Shares7,878filing
2026-07-15Lin XichenOfficer (CHIEF SCIENTIFIC OFFICER)M sell10b5-123,634 23,634 Ordinary Shares166,532filing
2026-07-15Lin XichenOfficer (CHIEF SCIENTIFIC OFFICER)C sell10b5-123,6340228,960−9%−0.01% (now 0.11%)filing
2026-07-15Lin XichenOfficer (CHIEF SCIENTIFIC OFFICER)M buy10b5-123,6340$0.34$8.0K252,594+10%+0.01% (now 0.12%)filing
2026-06-29Lin XichenOfficer (CHIEF SCIENTIFIC OFFICER)S sell10b5-17,878 23,634 Ordinary Shares$49.08$386.6K0filing
2026-06-29Lin XichenOfficer (CHIEF SCIENTIFIC OFFICER)C buy10b5-17,878 23,634 Ordinary Shares7,878filing
2026-06-29Lin XichenOfficer (CHIEF SCIENTIFIC OFFICER)M sell10b5-123,634 23,634 Ordinary Shares190,166filing
2026-06-29Lin XichenOfficer (CHIEF SCIENTIFIC OFFICER)C sell10b5-123,6340228,960−9%−0.01% (now 0.11%)filing
2026-06-29Lin XichenOfficer (CHIEF SCIENTIFIC OFFICER)M buy10b5-123,6340$0.34$8.0K252,594+10%+0.01% (now 0.12%)filing
2026-06-18Waldstreicher JoanneDirectorA buy39,453 39,453 Ordinary Shares39,453filing
2026-06-18TETLOW SHARONDirectorA buy39,453 39,453 Ordinary Shares39,453filing
2026-06-18WELCH DANIEL GDirectorA buy39,453 39,453 Ordinary Shares39,453filing
2026-06-18Russell Angus C.DirectorA buy39,453 39,453 Ordinary Shares39,453filing
2026-06-18LOVE TED WDirectorA buy39,453 39,453 Ordinary Shares39,453filing
2026-06-18DOBMEIER ERICDirectorA buy39,453 39,453 Ordinary Shares39,453filing
2026-04-23Lang MatthewOfficer (COO & GC)A buy223,776 223,776 Ordinary Shares223,776filing
2026-04-23Lang MatthewOfficer (COO & GC)A buy184,6140184,614new+0.09% (now 0.09%)filing
2026-04-16FMR LLC10% owner, See Remark 1S sell16,085 48,255 Ordinary Shares$55.07$885.8K32,171filing
2026-04-16FMR LLC10% owner, See Remark 1S sell1,367 4,101 Ordinary Shares$55.07$75.3K2,736filing
2026-03-23Yoon JunOfficer (CHIEF FINANCIAL OFFICER)A buy128,892 128,892 Ordinary Shares128,892filing
2026-03-23Yoon JunOfficer (CHIEF FINANCIAL OFFICER)A buy104,08501,401,656+8%+0.05% (now 0.66%)filing
2026-03-23Stevens Raymond CDirector, Officer (CHIEF EXECUTIVE OFFICER)A buy322,230 322,230 Ordinary Shares322,230filing
2026-03-23Stevens Raymond CDirector, Officer (CHIEF EXECUTIVE OFFICER)A buy260,21701,401,593+23%+0.12% (now 0.66%)filing
2026-03-23Ma YingliOfficer (CHIEF TECHNOLOGY OFFICER)A buy40,278 40,278 Ordinary Shares40,278filing
2026-03-23Ma YingliOfficer (CHIEF TECHNOLOGY OFFICER)A buy32,5260139,917+30%+0.02% (now 0.07%)filing
2026-03-23Lin XichenOfficer (CHIEF SCIENTIFIC OFFICER)A buy53,703 53,703 Ordinary Shares53,703filing
2026-03-23Lin XichenOfficer (CHIEF SCIENTIFIC OFFICER)A buy43,3680228,960+23%+0.02% (now 0.11%)filing
2026-03-23Hall AshleyOfficer (Chief Development Officer)A buy59,073 59,073 Ordinary Shares59,073filing
2026-03-23Hall AshleyOfficer (Chief Development Officer)A buy47,7060155,187+44%+0.02% (now 0.07%)filing
2026-03-23Coll Crespo BlasOfficer (CHIEF MEDICAL OFFICER)A buy93,984 93,984 Ordinary Shares93,984filing
2026-03-23Coll Crespo BlasOfficer (CHIEF MEDICAL OFFICER)A buy75,8970280,878+37%+0.04% (now 0.13%)filing

Up to 200 most recent filings · select a heading to sort, or open “How to read this” above for definitions · this company on SEC EDGAR.